Physician profile
Jonathan S Edelson
NPI 1548225097
$1,038.30
in general payments reported to CMS, 2019-2025
16 companies · $240 in 2025
The $240 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $47.45 · 2021: $101 · 2022: $128 · 2023: $291 · 2024: $119 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $634 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.85 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $371.22 | 2019-2023 | Trelegy Ellipta |
| Genzyme Corporation | $131.42 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $129.83 | 2023 | Dupixent |
| Regeneron Pharmaceuticals, INC. | $126.29 | 2025 | Dupixent |
| Inogen, INC. | $60.81 | 2024 | |
| Fisher & Paykel Healthcare INC | $43.37 | 2022 | |
| Sunovion Pharmaceuticals INC. | $28.57 | 2019 | |
| Inspire Medical Systems, INC. | $24.53 | 2025 | Inspire |
| Genentech USA, INC. | $16.49 | 2019 | |
| Insmed, INC. | $16.24 | 2024 | Arikayce |
| Philips North America LLC | $15.91 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $15.42 | 2020 | |
| Paratek Pharmaceuticals, INC. | $15.27 | 2021 | |
| United Therapeutics Corporation | $14.83 | 2021 | |
| Grifols USA, LLC | $14.80 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $13.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Edelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.